Why the study?
How does age affect the clinical presentation, laboratory features, and outcomes in patients with pulmonary embolism?
How does age affect the clinical presentation, laboratory features, and outcomes in patients with pulmonary embolism?
Advanced age in patients with pulmonary embolism is associated with distinct clinical presentations, higher biomarker levels, and potentially higher mortality when excluding underlying malignancy.
May guide age-conscious biomarker use in PE; leaves open whether age-specific thresholds improve risk prediction.
Objective. The relation between age and clinical presentation of pulmonary embolism (PE) is not investigated in details. Methods. One hundred and seventy two consecutive patients with PE treated in the period of five years in the single center were enrolled in this study. According to age, patients were divided into tertiles, I ≤ 54 years, II 54-70 years and III > 70 years. Patients' characteristics, Wells score, risk distribution, basic symptoms, ECG signs, laboratory markers at admission and six-month outcome were compared between tertiles of age. Results. Patients in the third tertile were more often women, and had suffered more from common comorbidities. In the first tertile males and smokers predominated; patients had lower BMI and more frequently positive family history for venous thromboembolism. In the third tertile of age fewer patients were presented as a high probability Wells score and more patients could be classified as high-risk patients. Among ECG signs in the multivariant analysis only atrial fibrillation were significantly associated with advance age. Admission glycaemia, brain natriuretic peptide and d-dimers significantly increased and arterial oxygen pressure decreased across the tertiles no matter the presence of comorbidities which may have strong influence. The overall six-month mortality and major bleeding were not significantly different across the tertiles in whole group, but if we excluded patients with malignant disease, mortality rate was highest in the third tertile of age. Conclusion. In patients with PE there are several important differences in clinical presentation of PE which may have important influence on diagnostic procedures, therapy and outcome.
No takes yet. Share an insight, caveat, or question.
Džudović et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: